The Effect of Aripiprazole on Smoking Rate in Schizophrenic Patients
Not Applicable
- Conditions
- schizophrenia.The schizophrenic disorders are characterized in general by fundamental and characteristic distortions of thinking and perception, and affects that are inappropriate or blunted. Clear consciousness and intellectual capacity are usually maintained although
- Registration Number
- IRCT2013010512018N1
- Lead Sponsor
- Clinical Psychiatry Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 40
Inclusion Criteria
diagnosis of schizophrenia according to DSM IV TR criteria using semi-structured interviews,being in partial or complete remission phase, having necessary criteria for the diagnosis of nicotine dependence criteria according to DSM IV TR, aged 18 – 60 years, male sex.
exclusion Criteria: a history of allergy or any side effect due to Aripiprazole or other antipsychotics, dependency to other substances (based on the patient's history and morphine and methamphetamine test results at the time of intervention), comorbidity of the other major psychiatric disorders (such as unipolar and bipolar mood disorders), use of other drugs used for nicotine withdrawal, active phase of psychosis.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The rate of nicotine dependence. Timepoint: befor intervention and 6 weeks after intervention. Method of measurement: Nicotine Dependence Questionnaire (FAGERSTROM).
- Secondary Outcome Measures
Name Time Method Extrapyramidal side effects. Timepoint: befor intervention and 6 weeks after intervention. Method of measurement: abnormal involuntary movement scale.